Eli Lilly Q2 2026 earnings beat estimates as Mounjaro and Zepbound lift sales
Eli Lilly raised its 2026 revenue forecast after second-quarter sales rose 48%, led by Mounjaro and Zepbound despite lower prices.
Markets Writer
Maya breaks down the day's market action for people who don't stare at a Bloomberg terminal: what moved, why, and what it means for a normal portfolio.
Eli Lilly raised its 2026 revenue forecast after second-quarter sales rose 48%, led by Mounjaro and Zepbound despite lower prices.
CVS raised its 2026 outlook after reporting a second-quarter beat, while Aetna’s medical benefit ratio fell to 87.4%.
Jim Cramer said the fund’s forced unwind removed a seller from tech stocks, though the link to the rally remains his market view.
AMD reported 50% revenue growth and a Data Center surge, but shares fell in extended trading despite the earnings beat.
Qnity reported $1.43 billion in second-quarter revenue and lifted its 2026 targets, citing demand across its semiconductor materia...
TikTok users are listing purchases they consider worth the money, while planners point to prevention, time and retirement benefits...
Michigan Democrats vote for a Senate nominee as Abdul El-Sayed and Haley Stevens offer competing views on Israel, data centers and...
SpaceX’s public float, not its stock price, could triple as insider shares become eligible for sale after earnings.
An earnings call is a company presentation on recent results and outlook, usually followed by questions from analysts.
Cramer’s Aug. 4 watch list focused on lower oil, a possible S&P 500 record and earnings moves from Caterpillar to Pfizer.
Treasury Secretary Scott Bessent said Washington joined Japan’s yen purchases to curb disorderly moves and limit wider pressure on...
Trump and Republican leaders are sharpening attacks on progressive Democrats as both parties fight over the terms of the 2026 midt...